New blood test aims to spot liver cancer early, saving lives from cirrhosis
NCT ID NCT05971108
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This study is testing a new blood test called Elecsys GAAD to see if it can find liver cancer earlier in people with liver cirrhosis. Current methods often catch the cancer too late, leaving few treatment options. The study will compare the new test to standard care in 600 participants to see if it leads to earlier diagnosis and fewer unnecessary follow-up tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Manchester University NHS Foundation Trust
RECRUITINGManchester, Greater Manchester, M13 9WL, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.